Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125661132 | 12566113 | 2 | F | 201606 | 20160713 | 20160718 | 20160718 | EXP | US-GLAXOSMITHKLINE-US2016100715 | GLAXOSMITHKLINE | 66.97 | YR | M | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125661132 | 12566113 | 1 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), BID | Y | 0 | 1 | DF | INHALATION POWDER | BID | ||||||
| 125661132 | 12566113 | 2 | SS | COREG | CARVEDILOL | 1 | UNK, BID | 0 | BID | ||||||||||
| 125661132 | 12566113 | 3 | PS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK, PRN | UB9S | 20983 | ||||||||||
| 125661132 | 12566113 | 4 | C | ASPIRIN. | ASPIRIN | 1 | U | 0 | |||||||||||
| 125661132 | 12566113 | 5 | C | DIGOXIN. | DIGOXIN | 1 | U | 0 | |||||||||||
| 125661132 | 12566113 | 6 | C | INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | 1 | U | 0 | |||||||||||
| 125661132 | 12566113 | 7 | C | LASIX | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 125661132 | 12566113 | 8 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | U | 0 | |||||||||||
| 125661132 | 12566113 | 9 | C | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125661132 | 12566113 | 1 | Chronic obstructive pulmonary disease |
| 125661132 | 12566113 | 2 | Product used for unknown indication |
| 125661132 | 12566113 | 3 | Dyspnoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125661132 | 12566113 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125661132 | 12566113 | Dyspnoea | |
| 125661132 | 12566113 | Oxygen saturation decreased | |
| 125661132 | 12566113 | Respiratory disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125661132 | 12566113 | 1 | 2014 | 201606 | 0 | |
| 125661132 | 12566113 | 2 | 2013 | 0 | ||
| 125661132 | 12566113 | 3 | 2007 | 0 |